Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inder Anand

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
Circulation|August 30, 2021
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved TrialMilton Packer, Javed Butler, Faiez Zannad, et al.
JACC. Heart Failure|February 3, 2025
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Preserved TrialPeter Carson, John R Teerlink, Michel Komajda, et al.
The Lancet. Global Health|August 15, 2018
Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort studyTiew-Hwa K Teng, Jasper Tromp, Wan Ting Tay, et al.
Circulation|October 21, 2020
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced TrialMilton Packer, Stefan D Anker, Javed Butler, et al.
Diabetes Care|July 12, 2019
Microvascular Disease in Patients With Diabetes With Heart Failure and Reduced Ejection Versus Preserved Ejection FractionJasper Tromp, Shir Lynn Lim, Wan Ting Tay, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|September 13, 2011
Short-term mortality risk in emergency department acute heart failureW Frank Peacock, Richard Nowak, Robert Christenson, et al.
European Journal of Heart Failure|September 30, 2017
Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF studyPaul Welsh, Lei Kou, Changhong Yu, et al.
European Journal of Heart Failure|December 15, 2018
Impact of diabetes and sex in heart failure with reduced ejection fraction patients from the ASIAN-HF registryChanchal Chandramouli, Tiew-Hwa Katherine Teng, Wan Ting Tay, et al.
European Journal of Heart Failure|November 6, 2022
Association of post-vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high-risk cardiovascular disease: the INVESTED trialAlexander Peikert, Brian L Claggett, KyungMann Kim, et al.
JACC. Asia|December 14, 2023
Clinical Features of Heart Failure With Normal Ejection Fraction: Insights From the ASIAN-HF RegistryKanako Teramoto, Wouter Ouwerkerk, Wan Ting Tay, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Circulation|August 30, 2021
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved TrialMilton Packer, Javed Butler, Faiez Zannad, et al.
JACC. Heart Failure|February 3, 2025
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Preserved TrialPeter Carson, John R Teerlink, Michel Komajda, et al.
The Lancet. Global Health|August 15, 2018
Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort studyTiew-Hwa K Teng, Jasper Tromp, Wan Ting Tay, et al.
Circulation|October 21, 2020
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced TrialMilton Packer, Stefan D Anker, Javed Butler, et al.
Diabetes Care|July 12, 2019
Microvascular Disease in Patients With Diabetes With Heart Failure and Reduced Ejection Versus Preserved Ejection FractionJasper Tromp, Shir Lynn Lim, Wan Ting Tay, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|September 13, 2011
Short-term mortality risk in emergency department acute heart failureW Frank Peacock, Richard Nowak, Robert Christenson, et al.
European Journal of Heart Failure|September 30, 2017
Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF studyPaul Welsh, Lei Kou, Changhong Yu, et al.
European Journal of Heart Failure|December 15, 2018
Impact of diabetes and sex in heart failure with reduced ejection fraction patients from the ASIAN-HF registryChanchal Chandramouli, Tiew-Hwa Katherine Teng, Wan Ting Tay, et al.
European Journal of Heart Failure|November 6, 2022
Association of post-vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high-risk cardiovascular disease: the INVESTED trialAlexander Peikert, Brian L Claggett, KyungMann Kim, et al.
JACC. Asia|December 14, 2023
Clinical Features of Heart Failure With Normal Ejection Fraction: Insights From the ASIAN-HF RegistryKanako Teramoto, Wouter Ouwerkerk, Wan Ting Tay, et al.
Pageof 11